About: http://data.cimple.eu/news-article/608bab16a8b58d1b229b3598a4b470b0693293fd3263a97c91438ca1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/608bab16a8b58d1b229b3598a4b470b0693293fd3263a97c91438ca1 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line. Net profit for the first quarter rose 16 percent to $2.1 billion while sales increased by 11 percent. "COVID-19 did result in increased forward purchasing by customers, including at the patient level, as some patients filled prescriptions to cover a longer period of time," Novartis said. The pharma giant said the pandemic had had "no material impact on our underlying business, financial condition, cash collections or liquidity". Novartis added it feared no supply chain disruptions for most of its portfolio "at this time", and said it expected to be able to satisfy demand from continued forward purchases of drugs due to the pandemic. Consequently, it maintained its outlook for the full year 2020, in which it expects core operating income to rise by a high single or low double-digit percentage. Last week, Novartis announced it would sponsor a clinical trial in the US using hydroxychloroquine to treat patients hospitalised with COVID-19. Novartis said it had reached an agreement with the US Food and Drug Administration (FDA) to go ahead with a phase III clinical trial with around 440 patients to evaluate whether the drug is efficient in treating coronavirus. noo/jh/wdb
schema:headline	Novartis profit up as world flocks to buy medecine
schema:mentions	Novartis Supply chain Clinical trial Hydroxychloroquine Switzerland Food and Drug Administration Pandemic Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Earnings before interest and taxes Net income Market liquidity Microsoft Outlook
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-04-28 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software